본문 바로가기
KERD
논문KCI 등재

항혈소판약물과 생약제의 상호작용: 리뷰

A Review of Herbal Interactions with Antiplatelet Drugs

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objectives : Antiplatelet agents are commonly used worldwide for the prevention ofcardiovascular or cerebrovascular diseases by inhibiting platelet aggregation and thrombus formation. As the herbal medicine and crude drug market is gradually expanding with increasedpopularity, drug-herb interaction has become a rising topic. The most frequently interactingdrugs with herbs were reported to be antiplatelet agents and anticoagulants. The purpose of thisresearch is to focus on the interactions in antiplatelet agents with herbal medicines in order topresent safe use of these agents, including aspirin or clopidogrel, along with the effective use ofCAM (Complementary and Alternative Medicine). Methods : This research includes literatures on only the clinical results of drug interactions, primarilyassembled from PubMed and additionally from MedlinePlus Drugs and Supplements Directory, Martindale, Natural Standard, BNF, Stockely’s Herbal Medicines, etc. Results : Herbs that resulted in teractions with an antiplatelet agent were as follows : aloe vera,garlic, ginger, ginkgo, ginseng, and St. John’s wort. The results were all clinical and had morethan one case. Studies on garlic, ginger, and ginkgo were conducted on healthy adult subjectswhereas the clinical study on St. John’s wort was conducted on patients with stent placed ontheir coronary artery. Conclusions : Although clinical studies and cases on drug-herb interaction had varied results, theresults could lead to the conclusion that many herbal medicines will have interactions withantiplatelet agents. Therefore, potential interactions should be considered when simultaneouslyusing herbal medicine and conventional medicine prior to treatment. Further research using alarger population is required for more accurate results.

Abstract

Objectives : Antiplatelet agents are commonly used worldwide for the prevention ofcardiovascular or cerebrovascular diseases by inhibiting platelet aggregation and thrombus formation. As the herbal medicine and crude drug market is gradually expanding with increasedpopularity, drug-herb interaction has become a rising topic. The most frequently interactingdrugs with herbs were reported to be antiplatelet agents and anticoagulants. The purpose of thisresearch is to focus on the interactions in antiplatelet agents with herbal medicines in order topresent safe use of these agents, including aspirin or clopidogrel, along with the effective use ofCAM (Complementary and Alternative Medicine). Methods : This research includes literatures on only the clinical results of drug interactions, primarilyassembled from PubMed and additionally from MedlinePlus Drugs and Supplements Directory, Martindale, Natural Standard, BNF, Stockely’s Herbal Medicines, etc. Results : Herbs that resulted in teractions with an antiplatelet agent were as follows : aloe vera,garlic, ginger, ginkgo, ginseng, and St. John’s wort. The results were all clinical and had morethan one case. Studies on garlic, ginger, and ginkgo were conducted on healthy adult subjectswhereas the clinical study on St. John’s wort was conducted on patients with stent placed ontheir coronary artery. Conclusions : Although clinical studies and cases on drug-herb interaction had varied results, theresults could lead to the conclusion that many herbal medicines will have interactions withantiplatelet agents. Therefore, potential interactions should be considered when simultaneouslyusing herbal medicine and conventional medicine prior to treatment. Further research using alarger population is required for more accurate results.

참고문헌 (64)

  1. "The 10 leading causes of death bybroad income group" (2008)[URL]
  2. Chen Z.M, "CAST : randomised placebocontrolled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial)Collaborative Group", Lancet, 349, pp.1641~1649 (1997)
  3. International Stroke Trial Collaborative Group, "The International Stroke Trial (IST):A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435patients with acute ischemic stroke", Lancet, 349, pp.1560~1581 (1997)
  4. Cina C.A, "Carotid endarterectomy for symptomatic carotid stenosis (Cochrane Review on CDROM)", Cochrane Library Update Software, 1 (2001)
  5. CAPRIE Steering Committee, "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)", Lancet, 348, pp.1329~1339 (1996)
  6. Connolly S.J, "Effect of clopidogrel added to aspirin in patients with atrial fibrillation", N Engl J Med, 360(2), pp.2066~2078 (2009)
  7. "우리나라 국민의 한방의료 이용실태와 인식도"[URL]
  8. 보건복지부 한국보건사회연구원 보고서, "조재국", 한방 의료이용 및 한약소비 실태조사, ~ (2011)
  9. 한양약복합투여시 안전성 유효성 연구, "황영일", 보건복지부, ~ (2006)
  10. Ulbricht C., "Clinical evidence of herb-drug interactions:a systematic review by the natural standard research collaboration", Curr Drug Metab, 9, pp.1063~1120 (2008)
  11. Chan A.L., "Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugs", J Altern Complement Med, 17(6), pp.513~517 (2011)
  12. Christine A.H, "Dietary Supplement Adverse Events: Report of a One-Year Poison Center Surveillance Project", J Med Toxicol, 4(2), pp.84~92 (2008)
  13. 유광현, "고속 스크리닝 기법을 이용한 한약제제의 cytochrome P450 저해능 탐색", 생명과학회지, 17(3), pp.334~339 (2007), 한국생명과학회
  14. Kim N.J., "Studies on interactions between western and traditional herbal medicines - Effects of CHUNGHYULDAN on the pharmacokinetics and pharmacodynamics of nicardipine in rats", J Kor Soc Hosp Pharm, 19(4), pp.383~394 (2002)
  15. 천부순, "와파린과 생약제의 약물 상호작용 리뷰", 병원약사회지, 30(5), pp.450~470 (2013), 한국병원약사회
  16. 박수진, "국내 한약-양약 상호작용 연구논문 분석을 통한 상호작용 정보 현황파악 및 제공방안에 대한 연구", 동의생리병리학회지, 24(4), pp.543~552 (2010), 대한동의병리학회
  17. Badimon L., "Lipoproteins, platelets and atherothrombosis", Rev Esp Cardiol, 62(10), pp.1161~1178 (2009)
  18. Ruggeri Z.M., "Platelets in atherothrombosis", Nat Med, 8(11), pp.1227~1234 (2002)
  19. Vogler B.K., "Aloe vera: a systematic review of its clinical effectiveness", Br J Gen Pract, 49(447), pp.823~828 (1999)
  20. Vazquez B, "Antiinflammatory activity of extracts from Aloe vera gel", J Ethnopharmacol, 55(1), pp.69~75 (1996)
  21. Lee A., "Possible Interaction Between Sevoflurane and Aloe vera", Ann Pharmacother, 38(10), pp.1651~1654 (2004)
  22. Hirakata H., "Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity", Anesthesiology, 85(6), pp.1447~1453 (1996)
  23. Yokubol B, "Anesthesia with sevoflurane, but not isoflurane, prolongs bleeding time in humans", J Anesth, 13(4), pp.193~196 (1999)
  24. Kaye A.D., "Herbal medicines: current trends in anesthesiology practice-a hospital survey", J Clin Anesth, 12(6), pp.468~471 (2000)
  25. Larkin M., "Surgery patients at risk for herbanaesthesia interactions", Lancet, 354(9187), pp.1362~ (1999)
  26. Tsen L.C, "Alternative medicine use in presurgical patients", Anesthesiology, 93(1), pp.148~151 (2000)
  27. Yeh G.Y., "Use of complementary therapies in patients with cardiovascular disease", Am J Cardiol, 98(5), pp.673~680 (2006)
  28. Tattelman E., "Health effects of garlic", Am Fam Physician, pp.103~106 (2005)
  29. Lawson L.D., "Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products", Thromb Res, 65(2), pp.141~156 (1992)
  30. Apitz-Castro R., "Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets", Thromb Res, 42(3), pp.303~311 (1986)
  31. Beckert B.W, "The effect of herbal medicines on platelet function : an in vivo experiment and review of the literature", Plast Reconstr Surg, 120(7), pp.2044~2050 (2007)
  32. Wojcikowski K., "Effects of garlic oil on platelet aggregation: a double-blind placebo-controlled crossover study", Platelets, 18(1), pp.29~34 (2007)
  33. Kiesewetter H., "Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack", Eur. J Clin Pharmacol, 45(4), pp.333~336 (1993)
  34. Ali M., "Consumption of a garlic clove a day could be beneficial in preventing thrombosis", Prostaglandins Leukot Essent Fatty Acids, 53(3), pp.211~212 (1995)
  35. Steiner M., "Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions", J Nutr, 131(3), pp.980~984 (2001)
  36. Rahman K., "Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans", J Nutr, 130(11), pp.2662~2665 (2000)
  37. Rose K.D, "Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report", Neurosurgery, 26(5), pp.880~882 (1995)
  38. German K., "Garlic and the risk of TURP bleeding: A case report", Br J Urol, 76(4), pp.518~ (1995)
  39. Burnham B.E., "Garlic as a possible risk factor for postoperative bleeding", Plast Reconstr Surg, 95(1), pp.213~ (1995)
  40. Koo K.L., "Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation", Thromb Res, 103(5), pp.387~397 (2001)
  41. Young H.Y, "Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers", Am J Chin Med, 34(4), pp.545~551 (2006)
  42. Guh J.H., "Antiplatelet effect of gingerol isolated from Zingiber officinale", J Pharm Pharmacol, 47(4), pp.329~332 (1995)
  43. Guinot P, "Tanakan inhibits platelet-activatingfactor-induced platelet aggregation in healthy male volunteers", Haemostasis, 19(4), pp.219~223 (1989)
  44. Kim Y.S, "Antiplatelet and antithrombotic effects of a combination of ticlopidine and Ginkgo biloba Ext (EGb 761)", Thromb Res, 91(1), pp.33~38 (1998)
  45. Koch E, "Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts", Phytomedicine, 12(1), pp.10~16 (2005)
  46. Rowin J., "Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion", Neurology, 46, pp.1775~1776 (1996)
  47. Benjamin J., "A case of cerebral haemorrhage-can Ginkgo biloba be implicated?", Postgrad Med J, 77(904), pp.112~113 (2001)
  48. Vale S., "Subarachnoid haemorrhage associated with Ginkgo biloba", Lancet, 36, pp.9121~ (1998)
  49. Kellermann A.J., "Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy?", Pharmacotherapy, 31(5), pp.490~502 (2011)
  50. Rosenblatt M, "Spontaneous hyphema associated with ingestion of Ginkgo biloba extract", N Engl J Med, 336(15), pp.1108~ (1997)
  51. Kim B. H., "Influence of ginkgo biloba extract on the pharmacodynamics effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, twoperiod, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers", Clin Ther, 32(2), pp.380~390 (2010)
  52. Wolf H.R., "Does ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500mg daily?", Drugs R D, 7(3), pp.163~172 (2006)
  53. Lu W.J., "The effects of ergoloid mesylates and Ginkgo biloba on the pharmacokinetics of ticlopidine", J Clin Pharmacol, 46(6), pp.628~634 (2006)
  54. Aruna D., "Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects", Br J Clin Pharmacol, 63(3), pp.333~338 (2007)
  55. Gardner C.D, "Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial", Blood Coagul Fibrinolysis, 18(8), pp.787~793 (2007)
  56. Teng C.M., "Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng", Biochim Biophys Acta, 990(3), pp.315~320 (1989)
  57. Qi L.W., "Isolation and analysis of ginseng: advances and challenges", Nat Prod Rep, 28(3), pp.467~495 (2011)
  58. Lau W.C, "The effect of St John’s Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity", J Cardiovasc Pharmacol, 57(1), pp.86~93 (2011)
  59. Fessenden J.M, "Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy", Am Surg, 67(1), pp.33~35 (2001)
  60. 미래보건산업기술예측조사, "한국보건산업진흥원", 보건복지부, ~ (2006)
  61. H. Ishikawa, "The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial", Gut, 63(11), pp.1755~1759 (2014), BMJ[DOI]
  62. Thorat M.A, "Role of aspirin in cancer prevention", Curr Oncol Rep, 15(6), pp.533~540 (2013)

관련 논문AI추천

이 간행물의 다른 논문 (4건)